Display options
Cite
Laskowski LK, Nelson LS, Smith SW, et al. Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias". Clin Toxicol (Phila). 2016;54(5):467doi: 10.3109/15563650.2016.1159313.
Laskowski, L. K., Nelson, L. S., Smith, S. W., & Hoffman, R. S. (2016). Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias". Clinical toxicology (Philadelphia, Pa.), 54(5), 467. https://doi.org/10.3109/15563650.2016.1159313
Laskowski, L K, et al. "Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias"." Clinical toxicology (Philadelphia, Pa.) vol. 54,5 (2016): 467. doi: https://doi.org/10.3109/15563650.2016.1159313
Laskowski LK, Nelson LS, Smith SW, Hoffman RS. Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias". Clin Toxicol (Phila). 2016 Jun;54(5):467. doi: 10.3109/15563650.2016.1159313. Epub 2016 Mar 23. PMID: 27005678.
Copy Download .nbib Format: NLM
Share it on

Clin Toxicol (Phila). 2016 Jun;54(5):467. doi: 10.3109/15563650.2016.1159313. Epub 2016 Mar 23.

Authors' response to: "Beta-blocker treatment of caffeine-induced tachydysrhythmias".

Clinical toxicology (Philadelphia, Pa.)

L K Laskowski, L S Nelson, S W Smith, R S Hoffman

Affiliations

  1. a Ronald O. Perelman Department of Emergency Medicine , New York University School of Medicine , New York city , NY , USA ;
  2. b New York City Poison Control Center , New York city , NY , USA.

PMID: 27005678 DOI: 10.3109/15563650.2016.1159313

[No abstract available.]

Publication Types